Coronavirus Update: Merck cheers health experts with news antiviral cut risk of hospitalization and death by half in trial, and could become powerful tool in combating COVID-19


Merck cheered investors and healthcare experts alike on Friday with the news that its COVID-19 antiviral cut the risk of hospitalization or death by roughly half in a late-stage trial, and could become a powerful tool in reining in the pandemic.

Lawrence A. Cunningham’s Quality Investing: Higher taxes on stock dividends would hurt middle-class investors — especially retirees — far more than the wealthy

Previous article

Coronavirus Update: ‘This is a profound game changer’: Merck’s antiviral pill cuts risk of COVID-19 hospitalization and death in half, data show

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News